focus -WSS

focus

author：comprehensive 2025-09-29 18:15:29 - browse：64

Novo Nordisk headquarters -- health coverage from STAT — LISELOTTE SABROE/Scanpix/AFP via Getty Images

The release of Novo Nordisk’s latest earnings report on Thursday provided a chance for executives to tout their major win this week — outcomes from a large trial showing the company’s obesity drug Wegovy cut the risk of heart complications by 20%.

But once again, much of the attention was focused on the company’s struggles to meet what Novo CEO Lars Fruergaard Jørgensen referred to as the “overwhelming demand for Wegovy.”

Jørgensen reiterated that the company was racing to expand supply and had brought on more contract manufacturing support, but Novo said Thursday that the company would continue to restrict the availability of lower-strength starter doses in the United States to ensure that patients on the drug would not have their medication interrupted.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Affirmative action in medical school literally saved lives
Next article： DIEP, the 'gold standard' of breast reconstruction, is under threat

WSS

Guidelines to prevent youth baseball injuries need more muscle

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

Inside the fall of star MIT scientist David Sabatini

Alkermes shareholders re

Hollywood unions extend contract negotiations for actors

Continuity nursing helped my family in our darkest PICU moments

Wikipedia

focus

leisure time

Guidelines to prevent youth baseball injuries need more muscle

The high cost of giving birth even with insurance

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Apple is now the first public company to be valued at $3 trillion

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

These geoengineering technologies could help combat the climate crisis, scientists say

United colonoscopy coverage change 'may cost lives,' doctors say

George Santos makes 1st court appearance after pleading not guilty to 13 counts

focus

A new study asks: Are we harming blood donors by taking blood?

Hollywood unions extend contract negotiations for actors

Community addresses injustice for Long Island mothers

How one medical school became remarkably diverse

Psychedelics group wrestles with new pharma identity

Walensky prepares to leave CDC — and Congress — behind

hotspot

focus

focus

hotspot